Michael Farah

Board Member

Michael Farah has been involved in principal investing and investment banking since 2001. Prior to Linden, he was a Vice President at Metalmark Capital where he focused on healthcare investing. Mr. Farah began his career at UBS Investment Bank where he focused on M&A advisory and capital raising transactions for the healthcare sector and also spent three years with Summit Partners as a private equity associate.

Mr. Farah holds a Bachelor of Arts in Finance, with honors, from Carnegie Mellon University and an MBA from Harvard Business School.

Company Blog

January 15, 2020
Phase Appropriate Controls and GMPs in Cell and Gene Therapy
Compliance expert Benjamin Frey discusses the development of quality systems and controls for investigational… Read More
January 2, 2020
How to Safely Launch Medical Cannabis Products in Germany
Our expert's advice on how to navigate through the main challenges confronting you when… Read More
December 11, 2019
Five Steps Toward a Mature Data Integrity Culture
How can your company demonstrate the trustworthiness of GxP data as expected by regulators?… Read More
More Articles

UPCOMING Events

January 27, 2020
Pharmacovigilance and Risk Management Strategies Conference
DIA’s Pharmacovigilance and Risk Management Strategies Conference provides the foundation for strong str... Read More
February 18, 2020
SCOPE Summit 2020
Celebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. Over the co... Read More
March 23, 2020
DIA Medical Affairs and Scientific Communications Forum
DIA’s Medical Affairs and Scientific Communications Forum is designed for medical affairs professionals, b... Read More
All Events
Contact Us